Despite Congressional mandates aimed at diversifying clinical research, little has changed in the last 30 years in both the numbers of studies that include minorities and the diversity of scientists being funded, according to a new analysis by researchers at UC San Francisco.
Healing Hands: Pharmacist Janel Boyle, PharmD, PhD (far left), who is developing dosing models tailored for children, comforts a young patient with her mother in the infusion clinic at UCSF Benioff Children’s Hospital San Francisco.
Reprinted courtesy of UCSF Magazine.
In the pediatric bone marrow transplant clinic, pharmacist Janel Boyle’s past and present collide.
She drifts past young patients—many of them infants and toddlers—and notes their beaming smiles and balding heads. Her gaze shifts to the parents, their...
School faculty member Esteban G. Burchard, MD, MPH, has been appointed to an expert panel advising the National Institutes of Health (NIH) on how to develop President Barack Obama’s Precision Medicine Initiative.
I seek to understand, at the systems level, how biological networks within cancer cells are fundamentally different from those in normal cells. Using a variety of experimental techniques, I design new platforms for the rational application of personalized medicine and the design of combination...
I am a physician-scientist with training in pulmonary medicine, genetics, and epidemiology. My research and academic interests center on identifying disease risk factors specific to racial groups, most especially those related to asthma and drug response. I am engaged in a new, international field...
My work focuses on the translation of new technologies into improved patient outcomes, particularly the translation of personalized/precision medicine—targeting health care interventions to patients based on their genetics—into clinical care and health policy.
I investigate the causes of variations in clinical outcomes, using computational methods. My goal is to determine the optimal dosage, timing, and duration of therapeutic regimens. Ultimately, I want to develop precise, personalized treatments.
